| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.1M | — | +72.6% |
| R&D Expense | $49K | — | -47.9% |
| SG&A Expense | $3.2M | — | -48.2% |
| Operating Income | -$119K | — | +85.3% |
| Interest Expense | $7K | — | -98.8% |
| Net Income | $201K | — | +117.3% |
| EPS (Basic) | $0.01 | — | +125.0% |
| EPS (Diluted) | $0.01 | — | +125.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $40.2M | +9.2% | +77.2% |
| Accounts Receivable | $18.8M | -19.2% | +21.5% |
| Current Assets | $66.9M | -0.2% | +55.6% |
| Total Assets | $71.8M | +1.8% | +54.8% |
| Current Liabilities | $9.6M | -8.9% | +14.5% |
| Total Liabilities | $34.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.4M | — | +155.1% |
| Financing Cash Flow | $1.0M | — | +181.9% |
| -34.7% |
| Stockholders' Equity | $37.7M | +6.2% | +740.7% |